Home
Commodore Capital reported a 5.1% stake in Relmada Therapeutics RLMD · 5,505,527 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.1%
- Last report
- First report
- Shares held
- 5,505,527 sh
- Class
- Common stock, $0.001 par value per share
- Holder
- Commodore Capital
- Event date
- 26/04/27
- Filed
- 26/05/04
First 5%+ report · 5.1% stake
Relmada Therapeutics trades, last 26 weeks
What else happened in Relmada Therapeutics around then
Filed or reported within 30 days of the trade day · 03/28~05/27Commodore Capital's other 5% stake reports
- Commodore Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
- Commodore Capital
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
- Commodore Capital
5% stakePalisade Bio
5% stakePalisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeJatt II Acquisition
5% stakeJatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeRelay Therapeutics
5% stakeRelay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14